Doug Hampton

Bahnbrechende Studie validiert Allergen-Expositionskammer zur Bewertung der klinischen Ergebnisse der HDM AIT bei Patienten mit allergischer Rhinokonjunktivitis

by

HAMBURG, Deutschland, 11. Juni 2023 /PRNewswire/ — Eine Studie, die von Forschern des ALL-MED Medizinischen Forschungsinstituts und der Abteilung für Klinische Immunologie an der Medizinischen Universität Breslau in Polen durchgeführt wurde, hat die Verwendung einer Allergen-Expositionskammer (Allergen Exposure Chamber, AEC) zur Bewertung der klinischen Ergebnisse der Allergen-Immuntherapie (Allergen Immunotherapy, AIT) bei Hausstaubmilben (House Dust Mite, HDM) … Read more

Neues adaptives Studiendesign unterstützt die Bewertung von Therapiestrategien für Allergiepatienten

by

HAMBURG, Deutschland, 11. Juni 2023 /PRNewswire/ — Allergische Rhinitis (AR) und Rhinokonjunktivitis, häufige chronisch entzündliche allergische Erkrankungen, die die oberen Atemwege betreffen, haben erhebliche Auswirkungen auf die Weltbevölkerung. Die Prävalenz von AR reicht von 17 % bis 29 % in Europa und bis zu 20 % in den Vereinigten Staaten, wobei bis zu 40 % der … Read more

Groundbreaking Study Validates Allergen Exposure Chamber for Assessing Clinical Outcomes of HDM AIT in Allergic Rhinoconjunctivitis Patients’

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — A study conducted by researchers from the ALL-MED Medical Research Institute and the Department of Clinical Immunology at Wroclaw Medical University in Poland has validated the use of an allergen exposure chamber (AEC) in assessing the clinical outcomes of house dust mite (HDM) allergen immunotherapy (AIT) in patients with allergic … Read more

Studie zeigt vielversprechende Ergebnisse für Immuntherapie gegen Hautkrebs

by

HAMBURG, Deutschland, 11. Juni 2023 /PRNewswire/ — Eine bahnbrechende Studie wurde am 10. Juni auf dem Hybridkongress in Hamburg vorgestellt, der von der European Academy of Allergy and Clinical Immunology (EAACI) organisiert wurde. Die von Forschern des King’s College London und des Guy’s and St Thomas’ NHS Foundation Trust durchgeführte Studie hat vielversprechende Ergebnisse für … Read more

New Adaptive Trial Design Supports Evaluation of Therapeutic Strategies for Allergic Patients

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — Allergic rhinitis (AR) and rhinoconjunctivitis, common chronic inflammatory allergic diseases affecting the upper respiratory tract, have a significant impact on the global population. The prevalence of AR ranges from 17% to 29% in Europe and up to 20% in the United States, with seasonal allergic rhinitis (SAR) affecting up … Read more

Illumina announces CEO transition plan

by

SAN DIEGO, June 11, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina’s Chief Executive Officer and as a Director, effective Sunday, June 11. Charles Dadswell, Senior Vice President and General Counsel, … Read more

Study Shows Promising Results for Immunotherapy Targeting Skin Cancer

by

HAMBURG, Germany, June 11, 2023 /PRNewswire/ — A ground-breaking study was presented 10 June at the Hybrid Congress in Hamburg organized by the European Academy of Allergy & Clinical Immunology (EAACI). Study was conducted by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust has revealed promising results for a new … Read more

How to choose the right barbecue and succeed in grilling? Here are the tips of the French champion

by

the essential It’s hard to find your way around the profusion of barbecues available on the market today. And then, how to succeed in grilling? Follow the advice of an expert, Romain Gibert, French barbecue champion. As an expert, Romain Gibert has “plenty of barbecues”. And he is aware of the difficulty for a beginner … Read more